VADS; How far have we come?
Transcript of VADS; How far have we come?
![Page 1: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/1.jpg)
1
VADS; How far have we
come?
1
![Page 2: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/2.jpg)
2
Most Recent Period Estimates of Relative Survival Rates for Prostate
and Breast Cancer
Brenner H. Lancet. 2002;360:1131–1135.
Relative Survival Rate, % (SE)*
5 Years 10 Years 15 Years 20 Years
Breast cancer 86.4 (0.4) 78.3 (0.6) 71.3 (0.7) 65.0 (1.0)
Prostate cancer 98.8 (0.4) 95.2 (0.9) 87.1 (1.7) 81.1 (3.0)
*Rates derived from SEER 1973–1998 database (both sexes, all ethnic groups).
![Page 3: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/3.jpg)
3
HEART FAILURE SURVIVAL
3 NEJM 2009;361(23):2241-51. NEJM 2001;345(20):1435-43.
![Page 4: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/4.jpg)
4
Heart failure is in first place
®300,000 deaths in US per year
®500 deaths per 100,000 people per year in central Florida
®20,000 deaths in central Florida each year
®Progresses rapidly
![Page 5: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/5.jpg)
5
Heart Failure Options
Optimal medical management
Transplantation
Ventricular assist devices
–Rescue
–Bridge
–Destination
![Page 6: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/6.jpg)
Text Text
![Page 7: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/7.jpg)
7
First heart transplant- 1905
–Alexis Carrel
–Canine model
–Brief survival due to lack of immunosuppresion
First human heart transplant……
![Page 8: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/8.jpg)
8
![Page 9: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/9.jpg)
9
University of Mississippi Medical Center
90 minute survival
![Page 10: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/10.jpg)
10
December, 1967
Groot de Schoor Hospital, South Africa
Louis Washkansky
18 day survival
![Page 11: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/11.jpg)
11
![Page 12: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/12.jpg)
12
![Page 13: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/13.jpg)
13
![Page 14: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/14.jpg)
14
Donor limited
Graft failure
Transplant CAD
Immunosuppression
Cancer
10.6 year mean survival
![Page 15: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/15.jpg)
NUMBER OF HEART TRANSPLANTS REPORTED BY
YEAR
ISHLT 2008
NOTE: This figure includes only the heart transplants that are
reported to the ISHLT Transplant Registry. As such, this should
not be construed as evidence that the number of hearts
transplanted worldwide has declined in recent years.
J Heart Lung Transplant 2008;27: 937-983
![Page 16: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/16.jpg)
16
300,000 Heart Failure Deaths Per Year in U.S.
2500 transplants per year
16
![Page 17: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/17.jpg)
17
History
D. C. is a 53 year-old male with progressive congestive heart failure secondary to ischemic cardiomyopathy
CABG 9 years prior to presentation
Mitral valve replacement (St. Jude prosthesis) 3 years prior
Biventricular pacer/AICD placed 8 months prior
Being maintained on milrinone infusion
![Page 18: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/18.jpg)
18
Exam
WDWN male with mild dyspnea
Bilateral distended neck veins
Lungs- bibasilar rales
Heart- RRR crisp valve click
Ext- 1-2+ edema
![Page 19: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/19.jpg)
19
CXR
![Page 20: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/20.jpg)
20
![Page 21: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/21.jpg)
21
Summary
53 year old male with severe worsening CHF, ischemic cardiomyopathy, two previous median sternotomies, and a prosthetic mitral valve
![Page 22: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/22.jpg)
22
Operation
Jarvik 2000 LVAD implanted through left thoracotomy
Inflow/pump placed in left ventricular apex
Outflow placed in descending aorta
Device adjusted intra-operatively to ensure prosthetic mitral valve opening and closure
![Page 23: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/23.jpg)
23
![Page 24: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/24.jpg)
24
De-airing
![Page 25: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/25.jpg)
25 Freiburg, 8/01
![Page 26: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/26.jpg)
26
![Page 27: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/27.jpg)
27
Post Operative Course
Placed on aspirin, clopidogrel, and coumadin
No thrombo-embolic events
Had a barely palpable pulse, and no evidence of peri-valvular thrombosis
Transplanted 1 year later
Runs a barn building business
![Page 28: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/28.jpg)
28
12
![Page 29: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/29.jpg)
29
“It’s been a pleasure to be able to help people
and maybe you folks learned something” 1982
![Page 30: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/30.jpg)
30
Pulsatile VADs
1.0
0.8
0.6
0.4
0.2
0.0
0 6 12 18 24 30 36
Pr
[ali
ve]
Time (months)
OMM (n=61) +
+ + +
LVAD (n=68)
+ +
+ + + + + + +
+ + +
+ + +
* Rose et al,Long-term mechanical left ventricular assist
for end-stage heart failure.N Eng J Med.,2001;345:1435-1443
Transplantation
![Page 31: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/31.jpg)
31
What has changed since
REMATCH?
31
![Page 32: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/32.jpg)
32
Fluid Dynamic Blood Pumps
Axial flow
Centrifugal flow
![Page 33: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/33.jpg)
33
More is not better.
33
![Page 34: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/34.jpg)
34
Overflowing an LVAD leads to
right ventricular failure
• septum bows left
• RV architecture changes
• The RV is thin walled, so changes in
volume lead to large changes in wall stress
• Propofol can exacerbate right heart failure
34
![Page 35: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/35.jpg)
35
In acute RV failure, unloading
almost always leads to recovery
• post MI
• post PE
• post cardiotomy
35
![Page 36: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/36.jpg)
36
The heart can recover*.
36
![Page 37: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/37.jpg)
37
Acute Cardiogenic Shock Cells “hibernate” before they die
Rest Heart for Recovery Cells can recover
Infarct
LAD occlusion
WITHOUT
ventricular
unloading Massive Myocardial
Damage
LAD occlusion WITH
ventricular unloading Up to 5-times Reduction in Infarct
Size
•– Flameng et al JACC 2001
Acute Recovery with Ventricular assistance
![Page 38: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/38.jpg)
38
Acute Devices
• Impella
38
Centrimag
![Page 39: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/39.jpg)
39
Acute Cardiogenic Shock
• G.C.
• 57 yo male
• presented with acute LAD MI, EF<10%
• PCI- Reflow but no improvement in LV
function
• Multiple inotropes, pressors, Impella 2.5
• Transferred to our facility
39
![Page 40: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/40.jpg)
40
Echo
40
QuickTime™ and aMicrosoft Video 1 decompressorare needed to see this picture.
![Page 41: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/41.jpg)
41
POD#5
41
QuickTime™ and aMicrosoft Video 1 decompressorare needed to see this picture.
![Page 42: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/42.jpg)
42
Earlier is better
42
![Page 43: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/43.jpg)
43
IABP Score
Based on assessment one hour after implantation of IABP
Assigns points for
– High dose pressors (two points)
– Low urine output
– Low SVO2
– High PCWP
Circulation. 2002;106[suppl I]:I-203-I-206
![Page 44: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/44.jpg)
44
Temporary bridging can be important
Preserve end organ function
Salvage myocardium
Allow for complete evaluation
44
![Page 45: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/45.jpg)
45
FULL EVALUATION!
THERE ARE NO EMERGENCY DURABLE VAD IMPLANTS!
THERE ARE NO EMERGENCY CARDIAC TRANSPLANTS!
If the patient is too sick to be bridged, they are too sick for advanced therapy.
45
![Page 46: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/46.jpg)
46
Survival PRESENT DT HM II EXPERIENCE
1.0
0.8
0.6
0.4
0.2
0.0
0 6 12 18 24 30 36
Pr
[ali
ve]
Time (months)
OMM (n=61) +
+ + +
+ +
+ + + + + + +
+ + +
+ + +
Slaughter,et al NEJM 2009
Transplantation
HM II DT
![Page 47: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/47.jpg)
47
Yale experience with
Heartmate II
• November 2008- July 2011
• 15 patients
–13 bridge
–2 destination
47
![Page 48: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/48.jpg)
48
Survival Yale HM II EXPERIENCE
1.0
0.8
0.6
0.4
0.2
0.0
0 6 12 18 24 30 36
Pr
[ali
ve]
Time (months)
OMM (n=61) +
+ + +
+ +
+ + + + + + +
+ + +
+ + +
Slaughter,et al NEJM 2009
Transplantation
HM II DT
![Page 49: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/49.jpg)
49
Challenges
• Human factors
• Thromboembolism
• Mechanical/physiologic issues
• RV failure
• Bleeding
• Infection
• Power delivery
• Cost 49
![Page 50: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/50.jpg)
50
Human Factors
• Changing and charging batteries
• Taking anticoagulants
• Driveline care
50
![Page 51: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/51.jpg)
51
NATOPS
• 1950’s- 54 mishaps per 10,000 flight hours
• 1961- NATOPS established
• Current mishap rate- 2 per 10,000 flight
hours
51
![Page 52: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/52.jpg)
52
Mechanical/physiologic
• Axial flow pumps have not been pumped to
failure
• Aortic valve issues
• inflow conduit migration
52
![Page 53: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/53.jpg)
53
Unusual Aortic Valve Demands
• Continuous coaptation=fusion
• Persistent high trans-mural gradient =AI
Karen May-Newman, et al,”Geometry and Fusion of Aortic Heart Valves from Pulsatile Flow
Ventricular Assist Device Patients”Journal of Heart Valve Disease 2011;20: ??
AoV ΔP=0 AoV ΔP=60
![Page 54: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/54.jpg)
54
Continuous flow LVAD: Adverse
Effects on the Aortic Valve
3 years
May-newman K, Biomechanics of the aortic valve in the continuous flow
VAD-assisted heart. Am Soc Artif Intern Organs J 2010;56:301-308
Leaflet Elongation Leaflet Fusion
![Page 55: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/55.jpg)
55
• This aortic insufficiency occurs throughout
the cardiac cycle
• Potential solutions
– lower the gradient
–allow pulsatility
–close the aortic valve
55
![Page 56: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/56.jpg)
56
Inflow Conduit Migration
56
![Page 57: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/57.jpg)
57
Our Solution
57
![Page 58: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/58.jpg)
![Page 59: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/59.jpg)
59
Thrombosis: Expect the
unexpected
59
![Page 60: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/60.jpg)
60
QuickTime™ and aCinepak decompressor
are needed to see this picture.
![Page 61: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/61.jpg)
61
Infection and
Thromboembolism are Tightly
Coupled
61
![Page 62: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/62.jpg)
62
Driveline infections
• Better now
• ?Iatrogenic?
62
![Page 63: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/63.jpg)
63
Can we deliver power
wirelessly?
63
![Page 64: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/64.jpg)
64
Wardenclyffe 1901
64
![Page 65: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/65.jpg)
65
Witricity
65
![Page 66: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/66.jpg)
66
Thoratec Announces Development Agreement
With WiTricity For Proprietary Energy Transfer
Technology
By PR Newswire
05/10/11 - 04:30 PM EDT
66
![Page 67: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/67.jpg)
67
Cost
67
![Page 68: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/68.jpg)
68
Cost
• 1996- $50,000 per QALY
• 2008- $59,000
–Bridge to transplant VAD- $48,000-$78,000
–Destination/long term use VAD- $56,000
• Costs will decrease as competition hits the
market
• Cost per QALY will improve as technology,
knowlege and execution improve 68
![Page 69: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/69.jpg)
69
Summary
• VAD technology is making rapid progress
• The remaining challenges have plausible
solutions
• VADs will be in the next decade what
coronary bypass was at the end of the
twentieth century
69
![Page 70: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/70.jpg)
70
Long Term
• Heartmate II
70
![Page 71: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/71.jpg)
71
Resurrection Devices
• ???
71
![Page 72: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/72.jpg)
72
It takes a village
• Multi-disciplinary team
–Evaluation
–Pre-op optimization
–Peri-op management
–Long term follow-up
72
![Page 73: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/73.jpg)
73
The Future
73
![Page 74: VADS; How far have we come?](https://reader033.fdocuments.us/reader033/viewer/2022052106/6287bb48a0996427442c8c9d/html5/thumbnails/74.jpg)
74
Questions?
74